Literature DB >> 21317252

The probiotic Escherichia coli Nissle 1917 reduces pathogen invasion and modulates cytokine expression in Caco-2 cells infected with Crohn's disease-associated E. coli LF82.

Claudia Huebner1, Yaoyao Ding, Ivonne Petermann, Christoph Knapp, Lynnette R Ferguson.   

Abstract

Increased numbers of adherent invasive Escherichia coli (AIEC) have been found in Crohn's disease (CD) patients. In this report, we investigate the potential of the probiotic Escherichia coli Nissle 1917 (EcN) to reduce features associated with AIEC pathogenicity in an already established infection with AIEC reference strain LF82.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21317252      PMCID： PMC3067434          DOI： 10.1128/AEM.01601-10

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  21 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

Review 2.  A molecular strategy for the study of bacterial invasion.

Authors:  S Falkow; P Small; R Isberg; S F Hayes; D Corwin
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

3.  Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines.

Authors:  Claudia Huebner; Ivonne Petermann; Wen Jiun Lam; Andrew N Shelling; Lynnette R Ferguson
Journal:  Inflamm Bowel Dis       Date:  2010-02       Impact factor: 5.325

4.  Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells.

Authors:  J Boudeau; N Barnich; A Darfeuille-Michaud
Journal:  Mol Microbiol       Date:  2001-03       Impact factor: 3.501

5.  Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium.

Authors:  Christian Maaser; Lars Eckmann; Günther Paesold; Hyun S Kim; Martin F Kagnoff
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

6.  Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease.

Authors:  Margarita Martinez-Medina; Xavier Aldeguer; Mireia Lopez-Siles; Ferran González-Huix; Carles López-Oliu; Ghizlane Dahbi; Jesus E Blanco; Jorge Blanco; L Jesus Garcia-Gil; Arlette Darfeuille-Michaud
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

7.  Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.

Authors:  J Boudeau; A-L Glasser; S Julien; J-F Colombel; A Darfeuille-Michaud
Journal:  Aliment Pharmacol Ther       Date:  2003-07-01       Impact factor: 8.171

8.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

9.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.

Authors:  Arlette Darfeuille-Michaud; Jérôme Boudeau; Philippe Bulois; Christel Neut; Anne-Lise Glasser; Nicolas Barnich; Marie-Agnès Bringer; Alexander Swidsinski; Laurent Beaugerie; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

10.  A core gut microbiome in obese and lean twins.

Authors:  Peter J Turnbaugh; Micah Hamady; Tanya Yatsunenko; Brandi L Cantarel; Alexis Duncan; Ruth E Ley; Mitchell L Sogin; William J Jones; Bruce A Roe; Jason P Affourtit; Michael Egholm; Bernard Henrissat; Andrew C Heath; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962
View more
  12 in total

1.  Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage.

Authors:  Hanru Wang; Susan E P Bastian; Ker Y Cheah; Andrew Lawrence; Gordon S Howarth
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

2.  Transport proteins promoting Escherichia coli pathogenesis.

Authors:  Fengyi Tang; Milton H Saier
Journal:  Microb Pathog       Date:  2014-04-18       Impact factor: 3.738

3.  Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.

Authors:  Yanlong Jiang; Qingke Kong; Kenneth L Roland; Amanda Wolf; Roy Curtiss
Journal:  Pathog Dis       Date:  2014-03-11       Impact factor: 3.166

4.  Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA.

Authors:  Marita Gleinser; Verena Grimm; Daria Zhurina; Jing Yuan; Christian U Riedel
Journal:  Microb Cell Fact       Date:  2012-06-13       Impact factor: 5.328

5.  Porcine E. coli: virulence-associated genes, resistance genes and adhesion and probiotic activity tested by a new screening method.

Authors:  Peter Schierack; Stefan Rödiger; Christoph Kuhl; Rico Hiemann; Dirk Roggenbuck; Ganwu Li; Jörg Weinreich; Enrico Berger; Lisa K Nolan; Bryon Nicholson; Antje Römer; Ulrike Frömmel; Lothar H Wieler; Christian Schröder
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

6.  Substantial Extracellular Metabolic Differences Found Between Phylogenetically Closely Related Probiotic and Pathogenic Strains of Escherichia coli.

Authors:  Justin J J van der Hooft; Robert J Goldstone; Susan Harris; Karl E V Burgess; David G E Smith
Journal:  Front Microbiol       Date:  2019-02-19       Impact factor: 5.640

7.  A Novel Strategy to Study the Invasive Capability of Adherent-Invasive Escherichia coli by Using Human Primary Organoid-Derived Epithelial Monolayers.

Authors:  Aida Mayorgas; Isabella Dotti; Marta Martínez-Picola; Miriam Esteller; Queralt Bonet-Rossinyol; Elena Ricart; Azucena Salas; Margarita Martínez-Medina
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

Review 8.  Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic.

Authors:  Barbara De Conno; Marcella Pesce; Martina Chiurazzi; Marta Andreozzi; Sara Rurgo; Chiara Corpetti; Luisa Seguella; Alessandro Del Re; Irene Palenca; Giuseppe Esposito; Giovanni Sarnelli
Journal:  Foods       Date:  2022-04-04

9.  Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917.

Authors:  Clémence Massip; Priscilla Branchu; Nadège Bossuet-Greif; Camille V Chagneau; Déborah Gaillard; Patricia Martin; Michèle Boury; Thomas Sécher; Damien Dubois; Jean-Philippe Nougayrède; Eric Oswald
Journal:  PLoS Pathog       Date:  2019-09-23       Impact factor: 6.823

10.  Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917.

Authors:  Jun Xu; Kai Xia; Pinyi Li; Chenggong Qian; Yudong Li; Xinle Liang
Journal:  Appl Microbiol Biotechnol       Date:  2020-06-13       Impact factor: 4.813
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.